Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05233488
Other study ID # REC-43/02/008
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 12, 2022
Est. completion date December 10, 2023

Study information

Verified date September 2023
Source Cairo University
Contact Amr S Shalaby, Ph.D.
Phone 00201147718803
Email amr.saad@pt.cu.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The current study investigates the effect of different doses of pulses ultrasound therapy on different nerve conduction parameters of the median nerve in healthy volunteering subjects.


Description:

In the current study, we apply pulsed ultrasound therapy on median nerves of healthy volunteer subjects, at 1 W/cm2 10% duty cycle, 3 W/cm2 10% duty cycle, 1 W/cm2 50% duty cycle, and 3 w/cm2 50% duty cycle. Parameters of median nerve conduction study, Latency, amplitude, area, duration and forearm NCV are recorded before and after application of ultrasound therapy.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date December 10, 2023
Est. primary completion date November 10, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 24 Years
Eligibility Inclusion Criteria: 1. 120 hands of 60 subjects of both genders with age range 18: 24 years. 2. Subjects assigned will be apparently healthy subjects with no neurological or neuromuscular history affecting the upper limb. Exclusion Criteria: 1. Peripheral polyneuropathy. 2. Diabetes mellitus. 3. Previous surgeries or median and/or ulnar nerve release. 4. Cervical radiculopathy. 5. Median or ulnar entrapment neuropathies. 6. Previous or current pregnancies.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Pulsed Ultrasound Therapy
Ultrasound therapy is applied in the pulsed mode.

Locations

Country Name City State
Egypt Cairo University Giza

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary CMAP distal latency msecond Immediately after application
Primary CMAP amplitude mV Immediately after application
Primary CMAP duration msecond Immediately after application
Primary Nerve conduction study m/sec. Immediately after application
See also
  Status Clinical Trial Phase
Completed NCT00856011 - Nerve Morphology in Diabetic Patients N/A
Completed NCT00775333 - Nerve Entrapment in Diabetic Patients N/A